Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1-Reference-Cited by-同舟云学术

Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1

Published:2000-12 Issue:12 Volume:7 Page:1244-1252
ISSN:1350-9047
Container-title:Cell Death & Differentiation
language:en
Short-container-title:Cell Death Differ

Author:

Jourdan M,De Vos J,Mechti N,Klein B

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/4400758.pdf

Reference41 articles.

1. Greipp PR, Katzmann JA, O'Fallon WM and Kyle RA . 1988 Value of beta 2-microglobulin level and plasma cell labeling indices as prognostic factors in patients with newly diagnosed myeloma. Blood 72: 219–223

2. Drewinko B and Alexanian R . 1977 Growth kinetics of plasma cell myeloma. J. Nat. Cancer Inst. 58: 1247

3. Slifka MK, Antia R, Whitmire JK and Ahmed R . 1998 Humoral immunity due to long-lived plasma cells. Immunity 8: 363–372

4. Merville P, Dechanet J, Desmouliere A, Durand I, Debouteiller O, Garrone P, Banchereau J and Liu YJ . 1996 Bcl-2(+) tonsillar plasma cells are rescued from apoptosis by bone marrow fibroblasts. J. Exp. Med. 183: 227–236

5. Gu ZJ, Vos JD, Rebouissou C, Jourdan M, Zhang XG, Rossi JF, Wijdenes J and Klein B . 2000 Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors. Leukemia 14: 188–197

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pro-survival signaling regulates lipophagy essential for multiple myeloma resistance to stress-induced death;Cell Reports;2024-07

2. Comparative analysis of Bcl-2 family protein overexpression in CAR T cells alone and in combination with BH3 mimetics;Science Translational Medicine;2024-06-05

3. Co-operation of MCL-1 and BCL-XL anti-apoptotic proteins in stromal protection of MM cells from carfilzomib mediated cytotoxicity;Frontiers in Oncology;2024-04-08

4. Targeting MCL-1 protein to treat cancer: opportunities and challenges;Frontiers in Oncology;2023-07-31

5. Bone marrow microenvironment- induced regulation of Bcl-2 family members in multiple myeloma (MM): Therapeutic implications;Cytokine;2023-01